Methods: Between January 1999 and December 2011, eight cases (3 females, 5 males; mean age 41.5 years; range 30 to 66 years) who were operated due to leiomyoma were retrospectively analyzed. Age and sex of the patients, symptoms, localization of lesions, diagnosis, surgical modality, length of hospital stay and morbidity and mortality rates were reviewed.
Results: Six patients had dysphagia. Leiomyoma was localized at 1/3 mid-esophagus in five patients and at 1/3 distal esophagus in three patients. Three patients underwent thoracoscopic enucleation. Two patients underwent right thoracotomy, two with left thoracotomy and one with laparotomy and enucleation. The mean diameter of lesions was 5 cm (range, 2 to 7 cm). At three months following surgery, pseudodiverticulum was seen in one patient who underwent thoracoscopic enucleation. No intraoperative mortality was seen. The mean length of hospital stay was eight days (range, 5 to 12 days). During a mean follow-up of 16.4 months (range, 4 to 56 months), no recurrence or malignancy were observed.
Conclusion: Enucleation is an effective and safe diagnostic and therapeutic modality in patients with leiomyoma. Muscular layer should be also closed to prevent possible mucosal defects.
Leiomyomas of the esophageal wall grow slowly. They are usually asymptomatic and are discovered incidentally from observations made for other reasons. Resection in leiomyoma patients remains controversial; therefore, this study aims to evaluate the results of this surgical treatment.
Our data was obtained through patient files, recordings of surgical interventions, esophagoscopy and pathology reports, and outpatient clinical notes, and the results were compared with the data from the available literature.
Furthermore, all of the patients underwent esophageal myotomies. Enucleation was performed on the lesions, and solitary lesions were detected in all of the cases (Figures 1-3). After examination of the frozen sections, leiomyoma was confirmed, with the tumors having a mean lesion diameter of 5 cm (range, 2-7 cm). After the enucleation, saline was inserted into the enucleated area, and air was injected into the nasogastric tube to investigate the possibility of mucosal injuries, but none were reported. The esophageal muscle layers were then primarily closed with absorbable sutures, except for the first two cases which underwent a thoracoscopy. At the third postoperative month, a pseudodiverticulum was seen in one of these patients. The muscle layer of the third thoracoscopic case was also primarily closed. No perioperative mortality was seen in any of the cases, and the average length of hospital stay was eight days (range, 5-12 days). In addition, there was no recurrence or malignancy during the follow-up period, which averaged 16.4 months (range, 4-56 months). The clinical characteristics of the patients and treatment methods are summarized in Table 1.
Leiomyoma diagnosis is confirmed via a barium esophagogram, esophagoscopy, or CT. Esophageal leiomyomas can be seen as a posterior mediastinal mass on chest radiographs, but the radiological findings can be viewed as coincidental. A smooth, crescent-shaped filling defect can be seen at the mucosa of the anomaly-free esophagus contour on barium X-rays. The tumor is usually mobile during swallowing.[8-10] Leiomyomas have weak homogeneity in contrast CTs, and differential diagnoses resulting from neurofibroma, hemangioma, and other esophageal tumors, such as fibroma, are difficult.[7,9] They are usually seen as isointense submucosal lesions in MRI T2 sequences and can be distinguished from esophageal carcinoma by their high signal appearance in the T2 sequences.[9] Esophagoscopies preserve mucosal integrity, and smooth-edged lesions growing into the lumen are characteristically found via this procedure. Recently, endoscopic ultrasonography (EUS) has been extremely beneficial in the identification of benign lesions. However, it is not recommended for leiomyoma patients because needle aspiration is not suitable for them.[1,2,11] In this study, we utilized esophagoscopies and CT in all of the cases, and an MRI was also performed on two of the patients.
Malignant transformation is very rare in leiomyomas, with a reported rate of 0.2% in the literature.[1] In some instances, coincidental cases of esophageal carcinoma and leiomyoma have been reported.[12]
There is no consensus on the management of leiomyoma. Some authors have advocated removal, even if the patients are asymptomatic at diagnosis, whereas some have recommended frequent follow-up at regular intervals for asymptomatic patients and those with small leiomyomas. Both diagnosis and treatment are carried out at the same time during surgery. An operation is indicated in cases with a continued increase in tumor size and mucosal ulceration, which can also be used to facilitate histopathological diagnosis and other surgical procedures.[11] We think removal should be done in patients suspected of having leiomyomas, even if they are asymptomatic. If there is no treatment or if it is delayed, serious symptoms can present, and malignant transformation might even occur in the future, though this is a rare event.
Leiomyomas are located between the muscle layers and hold surrounding tissues loosely. They can be easily dissected with blunt dissection. For this reason, enucleation was our consensus choice for the surgical procedure. However, in rare cases where there is a very large tumor or leiomyomatosis, a resection may be required.[13,14]
Single or multiple tumors along with their size and localization can be used as guides for deciding whether a patient should have surgery. The surgical approach can be achieved by either a thoracotomy or thoracoscopy. Right thoracotomies are preferred since they provide excellent exposure for almost all transthoracic esophageal lesions. Left thoracotomies, thoracoabdominal incisions, or laparoscopies are preferred in lesions situated in the distal section.[11,13,15] In this study, we had five cases located in the middle third of the esophagus with right hemithorax, and we performed video-assisted thoracoscopic surgery (VATS) on three of the patients while two underwent thoracotomies. Enucleation was also performed in these cases since the surgeon had experience with this procedure. In addition, two of three cases with leiomyomas in the distal portion of the esophagus underwent left thoracotomies, and the other, which was located close to the gastroesophageal junction, had a midline laparotomy.
Bardini et al.[6] first described video thoracoscopic enucleation in esophageal leiomyomas in 1992. Since then, operative approaches have changed in favor of thoracoscopic procedures.[2] When compared with thoracotomies, VATS has cosmetic advantages while also providing less operative trauma, less pain, and better postoperative pulmonary functions. Video-assisted thoracoscopic surgery is also preferred when there is only a single esophageal leiomyoma measuring between 1 and 5 cm. The possibility of a thoracotomy increases with larger leiomyomas.[6,11,13,15] No intraoperative mortality has been reported with regard to esophageal leiomyomas treated with VATS enucleation. However, 13.3% of the patients experience a mucosal tear, 10% experience postoperative mucosal bulging, 3.3% have pleural effusion, and 3.3% suffer from epigastric pain.[13,16] In our study, three cases underwent thoracoscopic surgery, and in two of these, the tumor diameters were 6 cm and 7 cm. However, a thoracotomy was not needed for these patients.
There is no consensus in the literature regarding closing the myotomy area after enucleation. However, the general opinion is that re-emerging muscular layers are needed in order to prevent mucosal deformation.[13,16] Bardini and A solati[15] reported a pseudodiverticulum in a thoracoscopic resection case because the muscular layer had not been closed. In this study, all muscle layers were closed except for the two VATS cases, and a postoperative pseudodiverticulum was seen in the muscle layer in one of these patients. For this reason, we believe that the muscle layers should always be closed.
In addition, mucosal injuries should be kept in mind during leiomyoma enucleation. An unrecognized mucosal defect can lead to very serious postoperative outcomes. Hence, after enucleation, we administered saline to the enucleated area and pumped pressured air through a nasogastric probe to investigate the possibility of mucosal injuries in all of our thoracoscopic and surgical cases. In some cases, the hospital may make the patient to drink methylene blue when postoperative mucosal injury is suspected. Furthermore, draining methylene blue from a chest tube can be used for leakage control.[13,16]
Declaration of conflicting interests
The authors declared no conflicts of interest with
respect to the authorship and/or publication of this
article.
Funding
The authors received no financial support for the
research and/or authorship of this article.
1) Mutrie CJ, Donahue DM, Wain JC, Wright CD, Gaissert
HA, Grillo HC, et al. Esophageal leiomyoma: a 40-year
experience. Ann Thorac Surg 2005;79:1122-5.
2) Jiang G, Zhao H, Yang F, Li J, Li Y, Liu Y, Liu J, Wang
J. Thoracoscopic enucleation of esophageal leiomyoma: a
retrospective study on 40 cases. Dis Esophagus 2009;22:279-83. doi: 10.1111/j.1442-2050.2008.00883.x.
3) Facktor MA, Katlic MR. Benign tumors, cysts, and
duplications of the esophagus. In: Shields TW, LoCicero III
J, Reed CE, Feins RH, editor. General thoracic surgery. 7th
ed. Philadelphia: Wolters Kluwer & Lippincott Williams and
Wilkins; 2009. p. 1973-82.
4) Camp PC, Lukanich JM. Resection of benign tumors of the
esophagus. In: Sugarbaker D, Bueno R, Krasna M, Mentzer
S, Zellos L, editor. Adult chest surgery. China: McGraw-
Hill’s Access Surgery; 2009. p. 346-52.
5) Gayer CP, Edelman DA, Curtis B, Laker S, Webber J.
Combined endoscopic and laparoscopic approach to a
gastroesophageal tumor. JSLS 2011;15:228-31. doi: 10.4293
/108680811X13071180406790.
6) Bardini R, Segalin A, Ruol A, Pavanello M, Peracchia A.
Videothoracoscopic enucleation of esophageal leiomyoma.
Ann Thorac Surg 1992;54:576-7.
7) Karagülle E, Akkaya D, Türk E, Göktürk HS, Yildirim E,
Moray G. Giant leiomyoma of the esophagus: a case report and
review of the literature. Turk J Gastroenterol 2008;19:180-3.
8) Sidhu R, Sood BP, Kalra N, Vajpae K, Joshi K, Gupta NM,
et al. Imaging features of esophageal leiomyomatosis: a case
report. Clin Imaging 2002;26:293-5.
9) Jang KM, Lee KS, Lee SJ, Kim EA, Kim TS, Han D, et
al. The spectrum of benign esophageal lesions: imaging
findings. Korean J Radiol 2002;3:199-210.
10) Pujol J, Parés D, Mora L, Sans M, Jaurrieta E. Diagnosis and
management of diffuse leiomyomatosis of the oesophagus.
Dis Esophagus 2000;13:169-71.
11) Priego P, Lobo E, Alonso N, Gil Olarte MA, Pérez de
Oteyza J, Fresneda V. Surgical treatment of esophageal
leiomyoma: an analysis of our experience. Rev Esp Enferm
Dig 2006;98:350-8.
12) Mizobuchi S, Kuge K, Matsumoto Y, Yokoyama Y,
Ookawauchi K, Tamura S, et al. Co-existence of early
esophageal carcinoma and leiomyoma: a case report.
Jpn J Clin Oncol 2004;34:751-4.
13) Lee LS, Singhal S, Brinster CJ, Marshall B, Kochman
ML, Kaiser LR, et al. Current management of esophageal
leiomyoma. J Am Coll Surg 2004;198:136-46.
14) Rijcken E, Kersting CM, Senninger N, Bruewer M.
Esophageal resection for giant leiomyoma: report of two
cases and a review of the literature. Langenbecks Arch Surg
2009;394:623-9. doi: 10.1007/s00423-008-0365-8.